Accelerated Path to Cures (eBook, PDF)

Redaktion: Bassaganya-Riera, Josep

• Format: PDF

Produktbeschreibung

Details the role of modeling and computational approaches in precision medicine

Highlights the progress towards precision medicine

Advances Path to Cures

---

Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.

Produktdetails

• Verlag: Springer International Publishing
• Seitenzahl: 82
• Erscheinungstermin: 25. April 2018
• Englisch
• ISBN-13: 9783319732381
• Artikelnr.: 52940092

Autorenporträt

Dr. Josep Bassaganya-Riera is a serial entrepreneur and innovator who has served as the Director of the Nutritional Immunology and Molecular Medicine Laboratory (NIMML) at the Biocomplexity Institute of Virginia Tech since 2002. The NIMML tackles unsolved challenges in complex human diseases with unmet clinical needs. His research has received over $55 million in competitive R&D funding to combine advanced computational technologies with preclinical and clinical experimentation. The NIMML translates novel scientific discoveries into commercial applications that address unmet patient or consumer needs. Dr. Bassaganya-Riera has published over 150 peer-reviewed publications in reputable biomedical journals, founded 3 successful biotech companies (Pervida, Biotherapeutics and Landos Biopharma), and was recently named 2017 Innovator of the Year by the Roanoke-Blacksburg Technology Council. Dr. Bassaganya-Riera, and his companies have been active members of a statewide group that suppor

ts the planning behind the Governor's 2015 Virginia Bioscience Initiative. This initiative calls for Virginia to be in the top three pharmaceutical regions by 2023. Dr. Bassaganya-Riera was a featured presenter at the Governor's Forum on Bio and Big Data.

Inhaltsangabe

Chapter 1: Introduction to Accelerated Path to Cures and Precision Medicine in Inflammatory Bowel Disease.- Chapter 2: Computer-Aided Drug Discovery.- Chapter 3: Preclinical Studies: Efficacy and Safety.- Chapter 4: From Nutritional Immunology to Drug Development.- Chapter 5: Development of Synthetic Patient Populations and In Silico Clinical Trials.